Azilsartan medoxomil is a carboxylic ester obtained by formal condensation of the carboxy group of azilsartan with the hydroxy group of 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one. A prodrug for azilsartan, it is used for treatment of hypertension. Among its listed roles, it functions as a prodrug, an angiotensin receptor antagonist and an antihypertensive agent. It belongs to the class of benzimidazoles, a dioxolane, a cyclic carbonate ester, a 1,2,4-oxadiazole, an aromatic ether and a carboxylic ester. Functionally, it is related to azilsartan. It is the conjugate acid of azilsartan medoxomil(1-). It is grouped under the following drug class(es): Angiotensin II Receptor Blockers (ARBs). Its therapeutic use is listed as antihypertensives and cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Edarbi and Ipreziv. Its PubChem CID is 135409642.
Azilsartan medoxomil
| CAS No | 863031-21-4 |
|---|---|
| Molecular Formula | C30H24N4O8 |
| Molecular Weight | 568.5 g/mol |
| Synonyms | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Azilsartan medoxomil is a carboxylic ester obtained by formal condensation of the carboxy group of azilsartan with the hydroxy group of 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one.
The listed CAS number is 863031-21-4.
The listed molecular formula is C30H24N4O8.
The listed molecular weight is 568.5 g/mol.
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate.
The source lists Edarbi and Ipreziv.